Bacteriophage DNA glucosylation impairs target DNA binding by type I and II but not by type V CRISPR–Cas effector complexes
Marnix Vlot (Wageningen University & Research)
Joep Houkes (Wageningen University & Research)
Silke J.A. Lochs (Wageningen University & Research)
Daan C. Swarts (Universitat Zurich)
Peiyuan Zheng (University of Sheffield)
Tim Kunne (Wageningen University & Research)
Prarthana Mohanraju (Wageningen University & Research)
Carolin Anders (Universitat Zurich)
Martin Jinek (Universitat Zurich)
John van der Oost (Wageningen University & Research)
Mark J. Dickman (University of Sheffield)
S.J.J. Brouns (TU Delft - BN/Stan Brouns Lab, Kavli institute of nanoscience Delft, Wageningen University & Research)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
Prokaryotes encode various host defense systems that provide protection against mobile genetic elements. Restriction–modification (R–M) and CRISPR–Cas systems mediate host defense by sequence specific targeting of invasive DNA. T-even bacteriophages employ covalent modifications of nucleobases to avoid binding and therefore cleavage of their DNA by restriction endonucleases. Here, we describe that DNA glucosylation of bacteriophage genomes affects interference of some but not all CRISPR–Cas systems. We show that glucosyl modification of 5-hydroxymethylated cytosines in the DNA of bacteriophage T4 interferes with type I-E and type II-A CRISPR–Cas systems by lowering the affinity of the Cascade and Cas9–crRNA complexes for their target DNA. On the contrary, the type V-A nuclease Cas12a (also known as Cpf1) is not impaired in binding and cleavage of glucosylated target DNA, likely due to a more open structural architecture of the protein. Our results suggest that CRISPR–Cas systems have contributed to the selective pressure on phages to develop more generic solutions to escape sequence specific host defense systems.